Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. South Sweden Breast Cancer Group, and South-East Sweden Breast Cancer Group.
Fernö M, Stål O, Baldetorp B, Hatschek T, Källström AC, Malmström P, Nordenskjöld B, Rydën S. Fernö M, et al. Among authors: nordenskjold b. Breast Cancer Res Treat. 2000 Jan;59(1):69-76. doi: 10.1023/a:1006332423620. Breast Cancer Res Treat. 2000. PMID: 10752681 Clinical Trial.
Akt kinases in breast cancer and the results of adjuvant therapy.
Stål O, Pérez-Tenorio G, Akerberg L, Olsson B, Nordenskjöld B, Skoog L, Rutqvist LE. Stål O, et al. Among authors: nordenskjold b. Breast Cancer Res. 2003;5(2):R37-44. doi: 10.1186/bcr569. Epub 2003 Jan 20. Breast Cancer Res. 2003. PMID: 12631397 Free PMC article.
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.
Rydén L, Jönsson PE, Chebil G, Dufmats M, Fernö M, Jirström K, Källström AC, Landberg G, Stål O, Thorstenson S, Nordenskjöld B; South Swedish Breast Cancer Group; South-East Swedish Breast Cancer Group. Rydén L, et al. Among authors: nordenskjold b. Eur J Cancer. 2005 Jan;41(2):256-64. doi: 10.1016/j.ejca.2004.06.030. Eur J Cancer. 2005. PMID: 15661551 Clinical Trial.
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L, Jirström K, Bendahl PO, Fernö M, Nordenskjöld B, Stål O, Thorstenson S, Jönsson PE, Landberg G. Rydén L, et al. Among authors: nordenskjold b. J Clin Oncol. 2005 Jul 20;23(21):4695-704. doi: 10.1200/JCO.2005.08.126. J Clin Oncol. 2005. PMID: 16034044 Clinical Trial.
223 results